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AbstrAct
Objectives While the health and well-being benefits of 
physical activity are recognised, people with multiple 
sclerosis (MS) often face greater barriers than the general 
population. The Nintendo Wii potentially offers a fun, 
convenient way of overcoming some of these. The aim 
was to test the feasibility of conducting a definitive trial of 
the effectiveness and cost-effectiveness of Mii-vitaliSe; 
a home-based, physiotherapist-supported Nintendo Wii 
intervention.
Design A single-centre wait-list randomised controlled 
study.
setting MS service in secondary care.
Participants Ambulatory, relatively inactive people with 
clinically confirmed MS.
Intervention Thirty participants were randomised to 
receive Mii-vitaliSe either immediately (for 12 months) or 
after a 6-month wait (for 6 months). Mii-vitaliSe consisted 
of two supervised Nintendo Wii familiarisation sessions 
in the hospital followed by home use (Wii Sports, Sports 
Resort and Fit Plus software) with physiotherapist support 
and personalised resources.
Outcomes Included self-reported physical activity levels, 
quality of life, mood, self-efficacy, fatigue and assessments 
of balance, gait, mobility and hand dexterity at baseline, 6 
and 12 months. Interviews (n=25) explored participants’ 
experiences and, at study end, the two Mii-vitaliSe 
facilitators’ experiences of intervention delivery (main 
qualitative findings reported separately).
results Mean (SD) age was 49.3 (8.7) years, 90% female, 
with 47% diagnosed with MS <6 years ago and 60% new 
to active gaming. The recruitment rate was 31% (95% CI 
20% to 44%). Outcome data were available for 29 (97%) 
at 6 months and 28 (93%) at 12 months. No serious 
adverse events were reported during the study. Qualitative 
data indicated that Mii-vitaliSe was well-received. Mean 
Wii use across both groups over the initial 6-month 
intervention period was twice a week for 27 min/day. Mean 
cost of delivering Mii-vitaliSe was £684 per person.
Discussion Mii-vitaliSe appears acceptable and a future 
trial feasible and warranted. These findings will inform its 
design.
trial registration ISRCTN49286846
IntrODuctIOn
It is now widely recognised that physical 
activity provides many benefits for people with 
multiple sclerosis.1 2 These include improve-
ments in physical fitness, mobility, muscle 
strength as well as possible secondary bene-
fits such as improved quality of life, mood 
and well-being.3–7 Recent research suggests 
exercise is safe for people with MS with no 
increased risk of relapse or adverse events 
(AEs).8 However, people with MS typically are 
much less physically active than the general 
population.9 Keeping physically active can 
be challenging and people with MS face 
additional barriers.2 10–13 These include phys-
ical (eg, pain, fatigue, mobility and balance 
limitations, overheating), psychological (eg, 
fear, embarrassment or lack of confidence) 
and environmental (eg, transport, cost, lack 
of suitable facilities/trained staff) barriers.
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Research
strengths and limitations of this study
 ► Used a randomised controlled trial design and 
included mixed methods and a consideration of 
long-term follow-up.
 ► Adherence to the Mii-vitaliSe intervention was 
assessed by daily completion of a log.
 ► Mii-vitaliSe incorporated home-based use, 
personalised support and behaviour change 
techniques.
 ► Physical outcome assessments were not undertaken 
blinded to group allocation.
 ► Feasibility focus paves way for a definitive trial of the 
effectiveness and cost-effectiveness of Mii-vitaliSe.
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The Wii potentially overcomes some of these barriers 
by offering a relatively inexpensive, convenient, immer-
sive and fun way to exercise in the home.14 15 Recent 
physical activity guidelines for MS suggest working 
towards achieving 30 min of moderate aerobic activity 
twice a week and two sets of 10–15 repetitions of strength 
training exercises twice a week.16 However, as noted by 
de Souto Barreto, it is perhaps more important to get 
people who are currently inactive to do small amounts of 
activity even if they are not meeting guidelines for phys-
ical activity.17
While applications of the Wii are diverse and find-
ings have been promising,14 18 the evidence base in MS 
is limited19 20 with most studies small, preliminary and 
with limited follow-up.21–24 Nevertheless, early findings 
suggest the Wii is acceptable and enjoyable,25–27 safe for 
home use for those with mild MS symptoms,21 might be 
beneficial for balance24 26 and fitness21 and potentially 
results in greater adherence than traditional rehabilita-
tion programmes.28 29 It has been suggested that active 
gaming might have a ‘gateway effect’ increasing individ-
uals’ confidence and encouraging and enabling them to 
engage in other physical activity.30
In a non-randomised controlled trial (using a base-
line control period) involving a home-based Wii Fit 
programme of 14 weeks’ duration, Plow and Finlayson 
reported that use of the Wii had declined at 14 weeks.21 
They suggested that a more person-centred approach as 
well as the use of behaviour change techniques (such as 
motivational interviewing and problem solving) might 
help to improve longer term Wii use and foster intrinsic 
motivation. They highlighted the importance of consid-
ering individuals’ functional levels, environment and 
preferences when prescribing a Wii-Fit programme.31
Findings from a scoping review of the exergaming 
literature suggest the need for mixed methods trials 
that incorporate long-term follow-up and follow patients 
from the clinical setting to the home.32 A recent system-
atic review of behaviour change interventions to increase 
physical activity in people with MS concluded further 
research is required focusing on dose, long-term impact 
and method of delivery.33 Qualitative work undertaken 
in the USA suggests that people with MS would like to 
be given more information about the benefits of exercise 
from their healthcare providers, along with materials to 
support home and community exercise and tools/strate-
gies to support behaviour change.34
We have developed a physiotherapist-facilitated Wii 
intervention package that uses commercial software and 
aims to support people with MS to increase their phys-
ical activity levels (‘Mii-vitaliSe’).35 Our study design over-
comes some of the limitations highlighted in the literature 
by incorporating home-based activity, behaviour change 
techniques with personalised support, employing mixed 
methods and including a consideration of long-term 
follow-up.
Aim and objectives
The main aim of this pilot study was to assess the accept-
ability and suitability of Mii-vitaliSe and to establish 
whether a definitive multicentre randomised controlled 
trial to assess effectiveness and cost-effectiveness is feasible 
and, if so, to inform its design and conduct.
The specific objectives of the study were:
1. Test procedures (including administration of the 
self-reported outcomes and the physical assessments, 
delivery of the intervention, recording and monitoring 
of AEs), estimate recruitment and retention rates, 
and refine the selection of outcome measures in 
preparation for a definitive randomised controlled 
trial.
2. Collect data on the variability of outcome measures to 
inform a sample size calculation for a larger trial.
3. Estimate adherence rates via a self-reported daily play 
log (in terms of frequency, intensity, duration).
4. Determine the acceptability of study processes such as 
randomisation and of the Mii-vitaliSe intervention to 
participants and obtain information about patterns of 
use/barriers to use.
5. Gather feedback from physiotherapists about their ex-
periences of delivering Mii-vitaliSe.
6. Pilot a measure of healthcare resource use for a future 
economic evaluation.
MethODs
ethics and safety monitoring
The trial was overseen by a steering committee and is 
reported in accordance with the Consolidated Standards 
of Reporting Trials guidelines for pilot and feasibility 
studies.36 The study was reviewed and given a favourable 
opinion by the National Health Service (NHS) South 
Central Hampshire B Research Ethics Committee (ref: 
12/SC/0420). All participants gave written informed 
consent before taking part. Poole Hospital NHS Foun-
dation Trust was the study sponsor. A Safety Monitoring 
Committee comprising two independent advisors (a 
neurologist with expertise in MS and clinical trials and 
a physiotherapist with expertise in risk assessment and 
management of service users with neurological disability) 
reviewed any reported AEs and made recommendations 
to the study steering group.
study design
This mixed methods pilot study used a single-centre 
wait-list randomised controlled design.35 Participants 
were randomised to receive Mii-vitaliSe (plus usual care) 
immediately (immediate group) or after a 6-month delay 
(delayed group). Those in the immediate group received 
Mii-vitaliSe for approximately 12 months and those in 
the delayed group for approximately 6 months following 
a 6-month delay (during the delay they were asked to 
refrain from using the Wii). This design permitted a 
preliminary consideration of long-term (12 months) 
follow-up (immediate group only) (see Figure 1).
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Figure 1 Study design.
Semi-structured interviews (face-to-face at home) were 
undertaken by the study researcher with a purposive 
sample of participants at 6 and 12 months follow-up and 
at the end of the study with the two physiotherapists who 
delivered Mii-vitaliSe (study objectives 4 and 5).
A feasibility economic component was included to pilot 
the use of a healthcare resource use questionnaire and 
to capture costs related to delivering Mii-vitaliSe (study 
objective 6).
Participants
The main inclusion criteria were (i) a clinically definite 
diagnosis of MS; (ii) aged 18 years or above; (iii) satis-
fied a risk assessment (see below); (iv) relatively physically 
inactive (active for a period of 30 min or more on fewer 
than 5 days per week; (vi) having a suitable television at 
home.
The main exclusion criteria were (i) Adapted 
Patient Determined Disease Steps (APDDS) Scale37 
score of 1 or ≥6 (equivalent to an Expanded Disability 
Status Scale score of 1 or ≥6; (ii) a relapse within the 
past 3 months that required treatment with corticoste-
roids and/or a hospital admission; (iii) already partic-
ipating in exercise or rehabilitation research; (iv) a 
medical condition placing an individual at risk from 
exercise participation; (vi) owns a Wii and is currently 
using it on a weekly basis or more; (vii) unwilling or 
unable to comply with the protocol (eg, long vacation 
planned). The full eligibility criteria are described in 
the published protocol.35
sample size
As this was a pilot study designed to examine methodolog-
ical and procedural uncertainties of a future full-scale 
trial, we did not undertake a formal sample size calcula-
tion for clinical effectiveness. We used a sample size of 30, 
which is a common rule of thumb for pilot studies38 and 
adequate for the study objectives involving estimation 
of the recruitment rate, estimating the SD of potential 
primary outcomes and estimating adherence to the inter-
vention (for further details see published protocol35).
recruitment
Recruitment took place between February 2013 and July 
2013 with the last follow-up conducted in August 2014. 
Participants were recruited via multidisciplinary team 
members of an MS Service in a secondary care setting 
(Poole Hospital NHS Foundation Trust). Members of 
the team screened potential participants using a check-
list and, if they were eligible, either gave or sent them 
an invitation letter with a simple one page summary 
(‘Key Facts’) about the study, participant information 
sheets, the APDDS Scale,37 a brief question about current 
levels of physical activity, a reply slip and pre-paid enve-
lope. Those interested in participating or finding out 
more were asked to return the reply slip along with their 
responses to the questions. A follow-up reminder was sent 
with another copy of the information pack if no response 
was received.
screening and risk assessment
The study researcher (a senior lecturer in physio-
therapy) telephoned those expressing interest in the 
study, described the study in more detail, answered any 
questions and went through the remaining screening 
criteria. Those eligible were then visited at home for 
a risk and home suitability assessment undertaken by 
the study researcher. This involved an assessment of (i) 
ability to maintain standing balance with eyes open for 
1 min on the balance board; (ii) balance reactions and 
ability to step off safely from the balance board forwards, 
sideways and backwards; (iii) assessment of the home 
environment with minor environmental modifications 
suggested (if appropriate/possible). If participants 
satisfied the risk assessment criteria, they were asked 
to provide informed written consent and were then 
enrolled into the study.
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blinding
The nature of the intervention meant that participant 
blinding was not possible. The study researcher (not 
blinded to allocation) completed the physical assessments 
along with a clinical scientist (blinded to allocation). All 
other outcomes (with the exception of the activPAL accel-
erometer) were self-reported and administered postally 
(see 'Outcome measures' section for further detail).
study interventions
Mii-vitaliSe
The format and content of Mii-vitaliSe is summarised in 
the published protocol and its development is described 
in brief elsewhere.39 A consultation workshop was held to 
refine and optimise the Mii-vitaliSe intervention package. 
The workshop was attended by eight people with MS with 
experience of using the Wii and four health professionals 
from the research team (three physiotherapists and one 
psychologist). Table 1 summarises the timing, content and 
mode of delivery of Mii-vitaliSe. The rationale of Mii-vi-
taliSe is to support people with MS to increase activity 
levels in their own homes using the Nintendo Wii. Mii-vi-
taliSe encourages the internalisation of goals, and aims 
to provide individuals with skills, strategies and support 
to identify solutions to overcome barriers they encounter. 
The intervention draws on relevant psychological frame-
works and theories (motivational interviewing,40 social 
cognitive,41–43 cognitive behavioural44 and self-determi-
nation theory45) and incorporates behaviour change 
techniques.
A Mii-vitaliSe handbook (29 pages) provided informa-
tion about the benefits of physical activity and tips and 
advice for using the Wii safely and maintaining a physical 
activity programme, including quotations from people 
with MS with experience of using the Wii.
The intervention was personalised and this was 
achieved by the provision of regular one-to-one support 
from a physiotherapist (face-to-face and telephone) and 
a personal activity workbook (36 pages) that facilitated 
individualised goal setting, feedback, action and coping 
planning and monitoring of progress (Table 1). Partici-
pants were also provided with a ‘Play Log’ to encourage 
self-monitoring of activity/progress (see 'Process 
measures' section) and a set of descriptors of all the soft-
ware games with space for notes/comments.
Following the risk assessment in the home and two 
orientation sessions in the hospital, the Wii console was 
set up in participants’ homes. Participants were provided 
with commercially available software (Wii Fit Plus, Wii 
Sports and Wii Sports Resort) along with the Wii balance 
board (and non-slip cover), two Wii remote controls, two 
Nunchuk controls, battery and remote control chargers 
and spare rechargeable batteries. All participants were 
given a copy of the Mii-vitaliSe handbook and personal 
activity workbook presented in a ringbound folder.
The intervention was delivered by two Mii-vitaliSe facili-
tators (both senior physiotherapists). The study researcher 
undertook training in motivational interviewing (MI) 
and oriented the two Mii-vitaliSe facilitators to the MI 
approach.
usual care
The Dorset MS Service provides multidisciplinary 
support. Patients are reviewed annually by the team at an 
outpatient clinic or home visit appointment. On comple-
tion of the review and necessary assessments, medical and 
therapy treatments are delivered as required. If patients 
experience a deterioration of their symptoms before the 
next review they can self-refer to the service. Education, 
support and advice regarding disease modifying ther-
apies, management of symptoms and carer support is 
available from the specialist nurse. The team operates a 
helpline service Monday to Friday and messages can be 
left on an answer-phone outside the scheduled helpline 
hours.
randomisation
To ensure good allocation concealment, random alloca-
tion was email-based and administered by the study statisti-
cian. Randomisation was carried out in a one-to-one ratio 
and the sequence was produced using a computer-based 
random sequence generator. Variable-sized blocks were 
used to ensure approximately equal numbers in the two 
arms. No stratification was used.
Descriptors and outcome measures
At baseline, we gathered the following demographic and 
clinical descriptors: age, sex, ethnicity, disease type, time 
since diagnosis, relapses requiring corticosteroids and/or 
hospital admission, self-reported mobility (APDDS score), 
education, employment status, marital status, household 
composition.
As this was feasibility work, a broad range of outcomes 
was included encompassing physical activity, phys-
ical functioning, quality of life, mood and self-efficacy. 
Outcome measures were assessed at baseline and at 6 and 
12 months. Physical assessments were undertaken in the 
hospital setting and administered by the study researcher 
and a clinical scientist at similar times of the day wher-
ever possible to reduce the confounding effect of fatigue. 
Self-reported questionnaires (presented in a large font in 
a booklet format) were completed by participants in their 
homes at their own convenience and pace. For a more 
detailed description of outcome measures, see online 
web supplement 1.
Adverse events
All AEs and their possible relation to the Mii-vitaliSe 
intervention were closely monitored, documented and 
reported to the Study Safety Monitoring Committee. AE 
data were gathered via multiple sources: from the Dorset 
MS team, at physical assessment hospital visits, from 
the Mii-vitaliSe physiotherapists via face-to-face/tele-
phone contacts with participants, via daily play logs (see 
'Outcome measures' section) and during the qualitative 
interviews. These were collated by the study researcher 
and reviewed by the independent Safety Monitoring 
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Committee. The Chief Investigator assessed each AE to 
establish if it should be classified as a serious adverse 
event (SAE) according to the National Research Ethics 
Service definition (in terms of seriousness, relatedness 
and unexpectedness). As we were interested in the feasi-
bility and safety of the intervention, we gathered detailed 
information about AEs that were linked to Wii use even if 
these were expected and relatively minor (such as muscle 
ache, discomfort, pain).
Physical activity
Godin Leisure-Time Exercise Questionnaire (GLTEQ)46 47
This is a self-reported measure of usual physical activity 
that has been widely used in MS research. It consists of 
two items: the first measures frequency and intensity of 
exercise during free time in a typical week. These weekly 
frequencies are multiplied by metabolic equivalents and 
summed to form a measure of total leisure activity. The 
second question asks about the frequency of engaging 
in any regular activity long enough to work up a sweat 
with three response options provided (often, sometimes, 
never/rarely).
activPAL3 tri-axial accelerometer48 49
This classifies an individual's free-living activity into 
periods spent sitting, standing and walking and gives 
the number of steps and sit-to-stand episodes. At each 
assessment point participants were instructed to wear the 
activPAL for 24 hours/day for 7 consecutive days but to 
remove the device during water-based activities (show-
ering, bathing, swimming, etc). We did not specify which 
leg to attach it to as people could have had weakness in 
one leg.
Psychological well-being, quality of life
Hospital Anxiety and Depression Scale (HADS)50
The HADS is a self-report measure that incorporates an 
anxiety and a depression subscale. Each subscale consists 
of seven items with a 4-point Likert-type response scale. 
Higher scores indicate greater levels of anxiety and/or 
depression.
EuroQol-5 Dimensions-5 Levels (EQ-5D-5L)51
This is a measure of health status consisting of a descrip-
tive system (five dimensions: mobility, self-care, usual 
activities, pain/discomfort, anxiety/depression). Each 
dimension has five levels (no problems, slight prob-
lems, moderate problems, severe problems and extreme 
problems). We converted participants' responses to 
utility values using a value set for England.52 Addition-
ally, a visual analogue scale records respondents’ self-
rated health on a scale with end points labelled ‘the best 
health you could imagine’ and ‘the worst health you can 
imagine’. 
Multiple Sclerosis Impact Scale (MSIS-29)53
This scale measures the physical (20 items) and psycho-
logical impact (nine items) of MS on day-to-day life. It 
uses 5-point Likert-type response scales ranging from ‘not 
at all’ to ‘extremely’ and is based on quality of life in the 
last 2 weeks.
The Fatigue Symptom Inventory (FSI)54
The Fatigue Symptom Inventory is a 14-item self-report 
multidimensional questionnaire which measures the 
severity (four items), frequency (two items) and diurnal 
variation of fatigue (one item) and its perceived inter-
ference on quality of life (seven items). In the current 
study we report the severity and interference items and 
an interference summary score.
The Medical Outcomes Short-Form Survey V.2 (SF-36 v.2)55
The SF-36 v.2 measures eight dimensions of quality of 
life: physical functioning, role limitations because of 
physical health problems, bodily pain, general health 
perceptions, vitality, social functioning, role limitations 
because of emotional problems and mental health. In 
the current study we report only the Physical Component 
Summary (PCS) and the Mental Component Summary 
(MCS) scores. We also derived SF-6D utility scores from 
the SF-36.56
Self-efficacy
The Spinal Cord Injury Exercise Self-Efficacy Scale (SCI-ESES57
This scale was originally developed and validated in 
spinal cord populations. However, it has since been used 
in MS.11 It consists of 10 items that ask respondents to 
indicate their confidence in performing physical activi-
ties and exercise, with higher scores indicating higher 
perceived self-efficacy.
The Multiple Sclerosis Self-Efficacy (MSSE) Scale58
This 18-item scale comprises two subscales: (i) confi-
dence with function and (ii) confidence with ability to 
manage symptoms/cope with the demands of illness. In 
the current study, we only used the latter 9-item subscale.
Balance/gait/mobility
Two-Minute Walk Test (2MWT)59
This is a measurement of walking endurance by assessing 
walking distance over 2 min.
Step Test60
This is a test of dynamic standing balance. It involves 
recording the number of times a participant steps one 
foot fully on, then off, a 7.5 cm and 15 cm block as quickly 
as possible in two separate 15 s time periods, one for each 
foot leading.
Steady Stance Test61
The steady stance test measures the ability of an indi-
vidual to maintain a steady stance for a 60 s period in five 
predetermined stances without support (feet apart, feet 
together, stride stance, tandem stance, single leg stance).
Instrumented Timed Up and Go (i-TUG)62
This is a timed test used to examine functional mobility 
and requires the individual to stand up from a seated 
position, walk 3 m, turn, walk back and sit down. The 
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accelerometer and telemetry system were attached to the 
participant’s back with a strap. Three-axis accelerometer 
data were recorded in real-time on a PC via telemetry. 
Participants undertook one practice run followed by two 
recorded performances of the instrumented timed up 
and go test. Time to undertake the test was derived from 
the accelerometer data. Mean performance across the 
two recorded timed tests was used in the analysis.
Gait Stride-time Rhythmicity63
This was measured using a portable recorder connected 
to flat in-shoe heel impact sensors. Participants were asked 
to walk unaccompanied on an extended walk in a non-lab-
oratory setting along a covered and flat route (between 
200 and 250 steps per foot). They were instructed to walk 
at their normal pace without interruption and could use 
their normal orthotic or walking aid. The stride time 
between adjacent heel strikes was recorded for each 
foot separately and the mean and SD stride times were 
calculated.
Static Posturography64
The Poole Hospital Static Posturography System provided 
a method for objectively assessing balance via the tracking 
of limits of sway in a series of standardised conditions. It 
used ultrasound (transmitter was attached to the partici-
pant’s waist) time-of-flight posturography measurements 
to locate a participant’s centre of gravity (CoG) in a 
protocol mirroring the Equitest Sensory Organisation 
Test protocol.65 The motion of the CoG was accurately 
tracked during the course of 20 s assessment periods as 
the participant stood on either a solid or soft surface 
with eyes open or eyes closed or when doing a cogni-
tive distractor task. We report the Equilibrium Quotient 
per cent score (100−(anterior posterior maximum sway 
during 20 s/maximum anterior posterior movement 
possible without losing balance)×100). We note that the 
Wii balance board has been used as a tool for posturog-
raphy assessment.14 66 67
Hand dexterity/coordination
Nine-Hole Peg Test (9HPT)68
This timed test assesses finger and hand dexterity in both 
hands. It involves placing nine pegs into a peg board and 
then removing them as quickly as possible.
Process measures
Daily play log
This had a dual purpose of providing a means for partic-
ipants to self-monitor their Wii use as well as providing 
the research team with insights into levels and patterns of 
use. It included the following fields: date, whether played, 
adverse events (eg, pain, tenderness, soreness, fatigue, 
dizziness, headaches, aching, stiffness, falls or near falls), 
games played, total duration and number of bouts of 
activity, intensity,69 70 enjoyment and fatigue rating (on a 
scale of 1–10), reasons for non-use, free text comments. 
As we had concerns that asking people to complete a daily 
log might be onerous, we also tried out an alternative, 
briefer log for those in the immediate group from months 
6 to 12. This was a calendar format which simply required 
participants to either put a cross on the date to indicate 
non-use or to write down the duration played if they had 
used the Wii.
We originally envisaged that adherence would be oper-
ationalised as the total number of days on which activities 
were performed divided by the number of days agreed 
with the physiotherapist in a participant’s action plan. 
However, it became apparent that given our long-term 
timescales, the variability of MS and the frequent need to 
adjust goals (eg, to progress them or reduce them due to 
symptom fluctuations) that this definition was not prac-
tical. Instead we measured daily use (in terms of frequency, 
duration and intensity) or non-use use of the Wii. Play 
logs were collected from participants in the immediate 
group at the end of 6 months, and at 12 months from 
the delayed group. Due to resource and time constraints, 
we were not able to collect any data directly from the Wii 
consoles.
Resource use and intervention costs
We piloted a self-reported healthcare resource use ques-
tionnaire that we have used previously in a trial of MS 
fatigue.71 This questionnaire was administered at 6 and 12 
months postbaseline. As we were primarily interested in 
the feasibility of collecting these data and their complete-
ness, we present these data descriptively only. Intervention 
costs for delivery of Mii-vitaliSe are based on within-study 
data including work sampling forms completed by the 
Mii-vitaliSe facilitators to record preparation, contact and 
travel time. Facilitator costs were estimated using pounds 
sterling at 2013 unit costs.72
Interviews
Interviews (n=25) were conducted by the study researcher 
in people’s homes— 13 were undertaken at 6 months (7 
immediate and 6 delayed group) and 12 at 12 months (6 
immediate and 6 delayed group). These explored partici-
pants’ experiences of study participation and of receiving 
Mii-vitaliSe. The study researcher also conducted inter-
views at the study end with the two physiotherapists who 
had delivered Mii-vitaliSe. In this article, we focus on the 
acceptability of study processes, study design and of the 
Mii-vitaliSe intervention. The main findings from the 
qualitative component relating to barriers and facilitators 
to using the Wii will be reported in depth elsewhere.
statistical analysis
The analysis was undertaken using SPSS V.21. As this 
was a pilot study, the analysis is mainly descriptive.38 
Estimates of recruitment and retention rates and SDs of 
baseline potential primary outcomes are presented with 
95% CIs. Preliminary effect size estimates with 95% CIs 
are presented in order to inform our consideration of 
potential primary outcome measures for the future trial 
and the plausibility of effect sizes. Standardised effect 
sizes (Cohen’s d) were obtained by dividing effect sizes 
group.bmj.com on October 16, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
8 Thomas S, et al. BMJ Open 2017;7:e016966. doi:10.1136/bmjopen-2017-016966
Open Access 
by pooled baseline SD. Participants were analysed in 
the group they were randomised to and we attempted 
to collect outcome measures on everyone randomised. 
Missing data were assumed to be missing completely at 
random and no imputation methods were used. Analysis 
of covariance was used to estimate effect size for each 
outcome variable at 6 and 12 months follow-up, adjusting 
for their baseline values.
Adherence rates were estimated via the data from the 
play log. This was done in two different ways: (a) using 
day as the unit of analysis (ie, percentage of days used) 
and (b) using participant as the unit of analysis (ie, 
percentage of days of use for each participant was calcu-
lated and then averaged over all participants). Where a 
play log or calendar was not completed for one or more 
days, we made the conservative assumption that the Wii 
was not used; thus, Wii use might be underestimated. Wii 
use towards the end of the 12-month period was calcu-
lated from the last 30 days of follow-up in the immediate 
group. Descriptive statistics were used to summarise 
participants’ use of the Wii, including which games were 
used, intensity of exercise, time of day, reasons for not 
using the Wii and if they played the Wii, whether this was 
alone or with others.
Visual inspection of the ‘Activity Summary’ output 
by day and week provided by the activPAL software 
programme (V.7.2.32) was used to provide an estimation 
of the number of valid wear days for each participant per 
7-day administration period.
Qualitative analysis
The semi-structured interviews were transcribed verbatim 
and analysed thematically using a framework method.73 
Two researchers (ST, LF) familiarised themselves with the 
transcripts and developed an agreed coding scheme and 
analytical framework combining a priori issues from the 
original topic guide and emerging themes. These codes 
were then charted in a matrix. Data relating to the accept-
ability of the outcome measures were content analysed 
and summarised descriptively.
results
study procedures, recruitment and retention rates
The planned recruitment target of 30 people randomised 
was achieved. The recruitment rate was 31% (95% CI 
22% to 41%) with thirty people randomised of the 98 
who had been sent information packs (see Figure 2). We 
cannot comment on reasons for non-participation as the 
NHS Research Ethics Committee recommended that we 
did not use a decline slip in the study.
There were two dropouts in the immediate Mii-vi-
taliSe arm (for medical reasons) and these participants 
had incomplete follow-up data. Thus, 29 (97%) (95% CI 
83% to 99%) participants had complete self-reported 
questionnaire follow-up data at 6 months and 28 (93%) 
(95% CI 79% to 98%) at 12 months.
baseline characteristics
Ninety per cent of participants were female and 70% had 
a diagnosis of relapsing remitting MS. Mean (SD) age was 
49 (8.7) years with 47% diagnosed with MS for <6 years. 
Sixty per cent of the sample had not used a home gaming 
system before (see Table 2 and 3).
Outcome measures
As this was a pilot study, our focus is on presenting descrip-
tive data.38 We do, however, present preliminary estimates 
of effect size to inform our consideration of potential 
primary outcome measures.
Questionnaire booklet return rates were high. Each 
participant was administered a self-report questionnaire 
booklet on three separate occasions. Two participants 
withdrew from the study for medical reasons and were 
not sent questionnaires after they withdrew. Eighty-
seven questionnaires were returned completed (97% of 
the planned assessment occasions and 100% of those 
administered).
Overall, rates of missing data for the self-reported 
outcomes were low. Anecdotal comments made by 
several participants during the telephone screening and 
feedback from the semi-structured interviews suggested 
that some participants found it difficult to complete the 
APDDS Scale as they felt they did not fit into a single cate-
gory. When completing the Godin Leisure-Time Exercise 
Questionnaire, participants sometimes left blank spaces 
rather than putting zeros (~10% of responses). In this 
instance, if participants had completed at least one of the 
three weekly frequency items but left one or both of the 
others blank (and had completed other questionnaires), 
we assumed they intended zero. However, in a future 
trial it will be important to emphasise more strongly 
that a response should be made to all items, even if that 
response is zero.
The interview data indicated that while participants 
found the physical assessments undertaken in the 
hospital interesting and acceptable, they were quite tiring 
and it was sometimes inconvenient to have to travel to the 
hospital, particularly for those working full-time.
Table 4 presents descriptive statistics for candidate 
outcomes for a future definitive trial. Descriptive statistics 
for all other outcomes included in this feasibility study 
are presented in online supplementary Tables S1-S5. 
For the self-reported outcome measures all standardised 
effect sizes (SES) at 6 months were in the direction of 
benefit for the immediate group with the exception of 
those for the SF-36 PCS, the EQ-5D-5L VAS and derived 
single index value, the NHPT and 4/5 of the reported 
outcomes of the FSI. All the balance and gait measures 
produced SES in the direction of benefit. However, the 
CIs were wide and spanned zero.
activPAl data
Overall of 90 possible measurement occasions there were 
no data available for 6 (7%) occasions (baseline, n=2; 6 
months, n=1; 12 months, n=3). Of the 84 measurement 
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Figure 2 Consolidated Standards of Reporting Trials (CONSORT) diagram.
occasions with data, 65 had a full 7 days, 18 had 6 days 
and 1 had 5 days, Out of a maximum 630 days’ data (7 
days for each of 90 measurement occasions), data were 
available for 90%. Fourteen participants (47%) had the 
full 7 days’ data available for each measurement occasion 
and 24 (80%) had at least 6 days' data (see online web 
supplement 2, Table S6).
Some participants reported that if they attached the 
activPAL device using PAL stickies only (with no medical 
tape), the activPAL fell off their leg in bed at night and 
when removing clothes. We have contacted activPAL for 
advice and they recommended using a Nitrile sleeve in 
combination with waterproof tape to ensure a contin-
uous overnight recording and to make the device water 
resistant (so it can be worn in the shower). In the current 
study, we did not specify the leg on which to attach the 
activPAL. In a future trial, we would ask people to wear 
the activPAL on their stronger leg if there are differences 
in functioning.
Adverse events
During the study period, there were no SAEs reported. 
The following Wii Fit Plus-related AEs were logged during 
the trial or reported in the 12-month interviews:
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Table 2 Descriptive statistics for demographic and baseline characteristics of participants
Immediate  
(n=15)
Delayed
(n=15)
Total
(n=30)
Gender (n (%))
  Female 14 (93%) 13 (87%) 27 (90%)
  Male 1 (7%) 2 (13%) 3 (10%)
Age (years)
  Mean (SD) 50.9 (8.08) 47.6 (9.26) 49.3 (8.70)
  Range 37–63 33–65 33–65
Ethnicity
  White English 14 (93%) 13 (87%) 27 (90%)
  White other British 1 (7%) 0 1 (3%)
  Other white 0 (0%) 2 (13%) 2 (7%)
Disease type (n (%))
  Benign 0 (0%) 1 (7%) 1 (3%)
  Relapsing-remitting 12 (80%) 9 (60%) 21 (70%)
  Secondary progressive 3 (20%) 2 (13%) 5 (17%)
  Primary progressive 0 (0%) 1 (7%) 1 (3%)
  Participant states ‘do not know’ 0 (0%) 2 (13%) 2 (7%)
Years since diagnosis
  <1 year 1 (7%) 2 (13%) 3 (10%)
  1–5 years 7 (47%) 4 (27%) 11 (37%)
  6–10 years 3 (20%) 4 (27%) 7 (23%)
  11–15 years 2 (13%) 1 (7%) 3 (10%)
  >16 years 2 (13%) 4 (27%) 6 (20%)
Relapse in previous 6 months* (n (%))
*requiring corticosteroids or hospital admission
0 (0%) 0 (0%) 0 (0%)
Adapted Patient Determined Disease Steps (APDDS)  
score
  2 (noticeable symptoms, but mild) 3 (20%) 2 (13%) 5 (17%)
  3 (limitations with Activities of Daily Living (ADLs)) 0 (0%) 1 (7%) 1 (3%)
  4 (interferes with walking, can walk 300–500 m) 5 (33%) 2 (13%) 7 (23%)
  5 (can walk 100–200 m but often use a stick) 6 (40%) 10 (67%) 16 (53%)
  6 (need a stick or single crutch)† 1 (7%) 0 (0%) 1 (3%)
Education† (n (%))
†Highest qualification achieved:
  No qualifications 2 (13%) 0 (0%) 2 (7%)
  One or more GCSE (or equivalent) 2 (13%) 4 (27%) 6 (20%)
  One or more A level (or equivalent) 1 (7%) 2 (13%) 3 (10%)
  First degree (or equivalent) 2 (13%) 3 (20%) 5 (17%)
  Higher degree/professional qualification 2 (13%) 2 (13%) 4 (13%)
  Other 6 (40%) 4 (27%) 10 (33%)
Employment status
  In paid employment (>30 hours per week) 6 (40%) 3 (20%) 9 (30%)
  In paid employment (≤30 hours per week) 4 (27%) 5 (33%) 9 (30%)
  Self-employed 0 (0%) 1 (7%) 1 (3%)
  Not in paid employment (unemployed, in education, retired, 
looking after home)
5 (33%) 6 (40%) 11 (37%)
Continued
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Immediate  
(n=15)
Delayed
(n=15)
Total
(n=30)
Marital status (n (%))
  Married/cohabiting 11 (73%) 10 (67%) 21 (70%)
  Single 1 (7%) 3 (20%) 4 (13%)
  Separated/divorced 2 (13%) 1 (7%) 3 (10%)
  Widowed 1 (7%) 1 (7%) 2 (7%)
Household composition (n (%))
  One child or more living in household 2 (13%) 5 (33%) 7 (23%)
At screening (n (%)):
  Does not do 30 mins or more of activity that increases 
breathing rate on any days in a typical week
7 (47%) 6 (40%) 13 (43%)
Percentages rounded to nearest integer, and thus, might not sum exactly to 100%.
†While an APDDS score of ≥6 was an exclusion criterion this person’s APDDS score at screening was <6.
Table 2 Continued 
Table 3 Previous experience/use of technology reported at baseline (n=30)
Do not
use
Has used but 
no longer uses
Uses 
occasionally
Uses 
regularly
Unsure 
what this is
TV remote control - - 1 (3%) 29 (97%) -
Traditional mobile 7 (23%) 2 (7%) 5 (17%) 16 (53%) -
SMART phone 14 (47%) - - 16 (53%) -
Sat Nav 20 (67%) 1 (3%) 5 (17%) 4 (13%) -
Personal computer/laptop 3 (10%) 1 (3%) 5 (17%) 21 (70%) -
MP3 Player/iPod 14 (47%) 4 (13%) 5 (17%) 7 (23%) -
Touch screen tablet (eg, iPad) 14 (47%) 1 (3%) 6 (20%) 9 (30%) -
Handheld gaming system (eg, Nintendo DS) 22 (73%) 7 (23%) 1 (3%) - -
Home gaming system (eg, Nintendo Wii, Xbox, etc) 18 (60%) 8 (27%) 4 (13%) - -
Pain in leg when standing on balance board during 
Segway Circuit (Training Plus), overdoing it on Hula 
Hoop (Aerobics) and aggravating existing scar tissue, 
hurt back during Jackknife (Strength), discomfort in 
hand when doing the Warrior (Yoga), aggravating an 
existing knee injury while using the Wii, catching toe 
on balance board, falling when playing Balance Bubble 
(Balance), losing footing and near fall with Rhythm 
Parade (Training Plus), two near falls when doing the 
Basic Step (Aerobics) and one near fall when using the 
balance board when playing Perfect 10 (Training Plus).
None of the events was deemed of major concern by the 
Safety Monitoring Committee and as soon as we became 
aware of such issues they were followed up promptly by 
the Mii-vitaliSe facilitators and referred on if necessary. If 
appropriate, the participant was given advice about how 
best to adjust their Wii programme to minimise the likeli-
hood of a reoccurrence of an AE.
use and patterns of use
Around 20% of days in the log and calendar were left 
blank. We have assumed that the Wii was not used on these 
days, although this is likely to lead to an underestimation 
of use. The Wii was used on around 30% of days during 
the first 6 months of using the Wii (delayed and imme-
diate groups combined) and 19% of days in the second 
6 months (immediate group). Thirty per cent of days 
equates to about 2 days per week per person. Median 
percentage of days used over the first 6 months of having 
the Wii was 28% (95% CI 23% to 37%). In the imme-
diate group at 12 months follow-up, five participants’ 
calendars indicated they were using the Wii at least 20% 
of days in the second 6 months. Participants tended to 
exercise alone, in the morning or afternoon, with light-to-
moderate intensity. Balance exercises, yoga and aerobics 
were the most common activities used. The most frequent 
reasons for not exercising were no time, too tired and 
feeling unwell. Descriptive data are presented in Tables 
S7a & S7b (see online web supplement 2).
health economics component
Healthcare resource use questionnaire
Although this questionnaire states that all boxes should 
be completed even if the response is zero, participants 
sometimes left some boxes blank when asked about 
the number of contacts with various clinicians/health 
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Table 4 Descriptives and preliminary estimates of effect size (Cohen’s d) for candidate outcomes for the future trial
Means (SD) n
Numbers in bold indicate measurements taken after using Wii
*Numbers presented if different from those in CONSORT diagram
Baseline (T=0)
Neither group using Wii 
n=30
6 months (T=1)
Only immediate group 
using Wii n=29
12 months (T=2)
Both groups using 
Wii n=28
Godin Leisure-Time Exercise Questionnaire (higher scores indicate more activity)
  Imm (Wii after T=0) 11.07 (12.39) 14 22.46 (16.39) 13 28.00 (24.61)
  Delayed (Wii after T=1) 7.93 (11.43) 14 11.20 (9.77) 15 18.17 (17.57)
  Mean difference adjusted for baseline (95% CI) - 8.32 (−2.01 to 18.65) -
  Standardised effect size - 0.70 -
  Overall baseline SD (95% CI) 11.81 (9.33 to 16.07) - -
Multiple Sclerosis Self-Efficacy scale (higher scores more self-efficacy, potential range 0–12)
  Imm (Wii after T=0) 57 (16) 59 (20) 59 (19)
  Delayed (Wii after T=1) 62 (18) 58 (16) 60 (16)
  Mean difference adjusted for baseline (95% CI) - 4 (−8 to 15) -
  Standardised effect size - 0.23 -
  Overall baseline SD (95% CI) 16.83 (13.40 to 22.62) - -
Hospital Anxiety and Depression Scale—depression subscale (sum score) (higher scores more depression, potential range 
0–21)
  Imm (Wii after T=0) 5.70 (2.88) 5.14 (2.96) 4.96 (2.55)
  Delayed (Wii after T=1) 6.27 (2.84) 6.53 (2.75) 5.93 (3.84)
  Mean difference adjusted for baseline (95% CI) - −0.67 (-2.23 to 0.88) -
  Standardised effect size - −0.23 -
  Overall baseline SD (95% CI) 2.82 (2.25 to 3.80) - -
Hospital Anxiety and Depression Scale—anxiety subscale (sum score) (higher scores more anxiety, potential range 0–21)
  Imm (Wii after T=0) 8.53 (3.62) 8.07 (3.83) 7.31 (2.93)
  Delayed (Wii after T=1) 6.27 (3.28) 6.60 (3.81) 6.20 (4.93)
  Mean difference adjusted for baseline (95% CI) - −0.41 (-2.39 to 1.58) -
  Standardised effect size - −0.12 -
  Overall baseline SD (95% CI) 3.59 (2.86 to 4.82) - -
Spinal Cord Injury Exercise Self-Efficacy Scale (sum score) (higher scores more self-efficacy, potential range 10–40)
  Imm (Wii after T=0) 28.47 (6.63) 28.89 (4.96) 28.04 (6.62)
  Delayed (Wii after T=1) 28.33 (5.37) 26.27 (5.08) 29.93 (5.42)
  Mean difference adjusted for baseline (95% CI) - 2.47 (-0.59 to 5.52) -
  Standardised effect size - 0.41 -
  Overall baseline SD (95% CI) 5.93 (4.72 to 7.97) - -
Multiple Sclerosis Impact Scale-29 physical subscale (higher scores more impact (worse outcomes), potential range 0–100)
  Imm (Wii after T=0) 30.92 (9.37) 30.40 (11.09) 30.38 (13.75)
  Delayed (Wii after T=1) 28.91 (11.61) 30.58 (14.86) 31.88 (19.36)
  Mean difference adjusted for baseline (95% CI) - −1.89 (-7.89 to 4.11) -
  Standardised effect size - −0.18 -
  Overall baseline SD (95% CI) 10.42 (8.30 to 14.00) - -
Multiple Sclerosis Impact Scale-29 psychological subscale (higher scores more impact (worse outcomes), potential range 
0–100)
  Imm (Wii after T=0) 30.65 (17.45) 26.29 (18.27) 25.59 (16.06)
  Delayed (Wii after T=1) 28.33 (18.85) 30.37 (14.38) 28.17 (18.45)
Continued
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Means (SD) n
Numbers in bold indicate measurements taken after using Wii
*Numbers presented if different from those in CONSORT diagram
Baseline (T=0)
Neither group using Wii 
n=30
6 months (T=1)
Only immediate group 
using Wii n=29
12 months (T=2)
Both groups using 
Wii n=28
  Mean difference adjusted for baseline (95% CI) - −4.03 (-10.87 to 2.80) -
  Standardised effect size - −0.22 -
  Overall baseline SD (95% CI) 17.88 (14.24 to 24.04) - -
EuroQol-5 Dimensions-5 Levels—single derived index (higher scores better health, potential range −0.281 to 1.00)
  Imm (Wii after T=0) 0.76 (0.10) 0.74 (0.08) 0.78 (0.10)
  Delayed (Wii after T=1) 0.76 (0.09) 0.78 (0.10) 0.77 (0.11)
  Mean difference adjusted for baseline (95% CI) - −0.04 (-0.11 to 0.02) -
  Standardised effect size - −0.42 -
  Overall baseline SD (95% CI) 0.10 (0.08 to 0.14) - -
SF-6D derived health state utility value (higher scores better health, range 0.296 to 1.00)
  Imm (Wii after T=0) 0.63 (0.09) 0.63 (0.07) 0.63 (0.11)
  Delayed (Wii after T=1) 0.67 (0.10) 0.61 (0.07) 0.65 (0.13)
  Mean difference adjusted for baseline (95% CI) - 0.02 (-0.03 to 0.08) -
  Standardised effect size - 0.21 -
  Overall baseline SD (95% CI) 0.09 (0.07 to 0.13) - -
Instrumented Timed Up and Go (i-TUG) (s) (lower score better outcome)
  Immediate (Wii after T=0) 10.72 (3.11) 13 10.19 (2.40) 10.17 (2.57)
  Delayed (Wii after T=1) 11.06 (1.79) 15 11.59 (2.98) 11.05 (2.78)
  Mean difference adjusted for baseline (95% CI) - −1.06 (-2.70 to 0.58) -
  Standardised effect size - −0.42 -
  Overall baseline SD (95% CI) 2.45 (1.93 to 3.33) - -
Where high scores indicate better outcomes, positive effect sizes suggest benefit from the Wii. Where low scores indicate better outcomes, 
negative effect sizes suggest benefit from the Wii. Ns are presented if they differ from ns described.
Table 4 Continued 
professionals (10/57 (18%) of follow-up questionnaires). 
In these instances when participants had completed some 
categories but left some blank, we assumed they meant 
zero. In a future trial as we now have a better idea of the 
main resources used (and can draw on data from another 
full-scale trial we have conducted that used the same 
resource use questionnaire71), we will be able to reduce 
the number of categories that we include and hopefully 
reduce the number of blank fields. Descriptive data are 
presented in Tables S8a & S8b (see online web supple-
ment 2).
Intervention costs
The work sampling forms suggested that the mean time 
per participant spent by physiotherapists delivering 
Mii-vitaliSe was 12 hours with approximately half this time 
involving face-to-face contact (see Table S9, online web 
supplement 2). Using an estimated cost of £32 per hour72 
for a hospital physiotherapist equates to a per participant 
cost of the intervention of £384 for physiotherapy time. 
The equipment cost (Nintendo Wii console plus periph-
erals and software) was approximately £300 per unit. 
Thus, the estimated total cost of providing Mii-vitaliSe is 
£684 per person.
Acceptability of study design
While some participants felt disappointed on learning 
that they had been randomised to the delayed (6-month 
wait) group, this design was generally deemed accept-
able. In a definitive trial, this timeframe would limit 
scope for long-term follow-up. However, a 12-month 
delay was considered a long time to wait and it was 
felt this could deter people from wanting to take part. 
When we explored a design that involved a usual care 
comparator most said they would still be willing to 
participate in such a study as they were keen to help 
others and saw randomisation as ‘part and parcel’ of 
clinical trials.
Acceptability of the Mii-vitalise intervention—participants
Most study participants were positive about Mii-vi-
taliSe, which was seen to be an acceptable, fun and 
convenient way to increase physical activity levels. 
A couple of people found the Wii was not for them 
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despite initial enthusiasm about joining the study. The 
materials were seen to be comprehensive and helpful 
with people tending to use them most when they were 
first familiarising themselves with the Wii. Physiother-
apist contact time was considered to be about right 
by the majority of participants, was highly valued and 
considered important to ensure people were safe and 
adequately supported.
Participants reported a wide range of benefits 
related to both physical and mental health (eg, 
increased physical activity, improved mood, reduced 
stress, increased confidence, better sleep, improved 
balance, strength and posture, better coordination, 
improvements in walking and relief in symptoms 
such as pain and fatigue). Examples of improvements 
noticed in everyday life included: fewer pegs dropped 
when hanging out the washing, finding it easier to 
climb out of a shower, being able to dance more in 
time to music at a social event, greater accuracy and 
dexterity when reaching for door handles, being able 
to walk further. Some people reported that relatives/
friends had noticed improvements. For some the Wii 
appeared to act as a ‘gateway’ to other physical activi-
ties and to greater self-confidence.
Acceptability of Mii-vitalise—physiotherapist facilitators
The two physiotherapist facilitators enjoyed delivering 
Mii-vitaliSe, liked the collaborative delivery model 
and found it helpful working with people in their own 
homes. They were sometimes struck by how much more 
people were able to do in the familiar surroundings of 
their own home compared with the hospital setting. 
While they found the Mii-vitaliSe materials well-written 
and presented, they felt there was scope for a simplified 
version combining the guidance book and workbook into 
one resource. They suggested the following modifica-
tions to the intervention: (i) have the facilitators assess 
people in their own homes prior to the initial orientation 
session; (ii) deliver the first orientation session in a struc-
tured group format; (iii) provide training for facilitators 
in setting up the Wii equipment with telephone tech-
nical support available; (iv) provide fixed time slots for 
the monthly follow-up calls with participants; (v) provide 
formal training in motivational interviewing to all facilita-
tors if they do not already have these skills.
DIscussIOn
The findings suggest that Mii-vitaliSe was well received by 
the majority of participants and acceptable to the physio-
therapists delivering it. Study recruitment was successful, 
retention was good and attrition low. Participants found 
the questionnaires relevant and easy to complete (with 
the exception of the APDDS) and questionnaire comple-
tion rates were high. Use of the Wii was good (average of 
around 2 days per week) and approached aerobic activity 
guideline levels developed for MS.16 This fits in with public 
health recommendations to encourage modest increases in 
physical activity in those who are sedentary.17
Limitations of this study include that it took place in a 
single centre linked with a multidisciplinary MS team, 
which is not typical of services available to patients across 
the country. Second, administration of the physical 
outcome assessments was not undertaken by a blinded 
assessor. Third, males were under-represented. Finally, it is 
likely that there was a selection bias with those who enrolled 
in the study more likely to find active gaming appealing.
In terms of strengths, we have developed an intervention 
in line with the Medical Research Council guidance for the 
development of complex interventions74 that blends physio-
therapy and psychological approaches and with substantial 
service user input. The intervention incorporates behaviour 
change techniques and the study included mixed methods 
and a consideration of long-term follow-up.
While the current study involved use of the Nintendo 
Wii, technology moves at a swift pace and the Wii 
has since been superseded by the Wii U (which itself 
recently ceased production). The Wii U offers certain 
benefits in terms of its capability to support remote 
communication (via ‘Miiverse’) interaction, and 
competition. It enables the user to set up individual-
ised routines and has a personal trainer feature. Several 
participants in the current study said in the interviews 
that they would have liked to have been able to contact 
others in order to provide mutual encouragement and 
share tips. Having peer support may help to enhance 
people’s motivation and ongoing use. We conducted 
usability testing of the Wii U with four participants from 
the current study. Overall, they liked the Wii U and felt 
it had certain advantages including a wider range of 
games and possibilities for remote communication.
Looking ahead to a future definitive trial, the main 
contender for a primary outcome is the Godin Leisure-
Time Exercise Questionnaire. This had the largest stan-
dardised effect size and increased physical activity was a key 
benefit described by participants in the interviews.
Since we designed the protocol for the feasibility study, 
guidelines for core outcomes to include in exercise trials 
in people with MS have been published.75 Ideally, we 
would like to avoid or reduce the requirements for people 
to attend the hospital for the administration of outcome 
measures as feedback from this feasibility study suggested 
such visits can be tiring and inconvenient for people who 
are already experiencing fatigue. While patient-reported 
questionnaires and accelerometers can be administered 
postally without requiring trips to the hospital, assess-
ments such as the Timed Up and Go and the Two Minute 
or Six Minute Walk Test require assessor administration. 
It would be challenging to undertake these blinded in the 
home in the context of a randomised trial with a usual 
care comparator as the Wii equipment might be visible 
in the homes of those allocated to the Mii-vitaliSe arm. 
To finalise the outcome set for the future trial, we will 
consider the most recent literature and consult with 
service users.
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Our study is the first to report on home-based use of 
the Wii for people with MS in the UK. Overall, findings 
from this study are promising and support proceeding 
to a full-scale trial of effectiveness and cost-effective-
ness. We will refine the trial design, aspects of the inter-
vention and finalise outcome measures in the light of 
our experiences from this pilot study. This work has 
relevance for the development and evaluation of other 
interventions that incorporate technology and person-
alised support to enhance physical activity levels in 
long-term conditions.
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